Prognosis and Treatment



Lupus nephritis is a disease which can be managed and will need close interaction between you and your care team. Patients may need to take medication or be under treatment for many years. However, even patients who have less symptoms and less active disease should have periodic checkups.




LN can be treated with drugs that block the body’s immune system from attacking its own cells and tissues as well as drugs to control some of the other manifestations of SLE and LN. Part of the treatment can include:

• Corticosteroids and immunosuppressive drugs: these are medications used to block the immune system from attacking the kidneys.

> Steroids: work quickly and reduce inflammation by reducing the immune response

> Calcineurin inhibitors: Block the activation of certain parts of the immune system and can prevent inflammation and damage to the kidneys

> Chemotherapy: some patients may be treated with a chemotherapy drug that reduces the activity of the immune system

> Antimetabolites: reduce the activity of the immune system by targeting enzymes

• Hydroxychloroquine: is an antimalarial drug that in lupus patients helps to regulate the immune system.

• Monoclonal antibodies: may be used to reduce the activity of the immune system, which can help to reduce SLE and LN symptoms.

• Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs): these drugs are used to control the blood pressure.

• Diuretics: these medications help your body and kidneys get rid of the excess liquid and swelling. They also work for controlling the blood pressure.

• Diet improvements: reducing salt intake (sodium) and protein in the daily diet can help lighten the burden on the kidneys.



1. Anders HJ, Saxena R, Zhao MH, Parodis I, Salmon JE, Mohan C. Lupus nephritis. Nat Rev Dis Primers. 2020 Jan 23;6(1):7. Doi: 10.1038/s41572-019-0141-9. PMID: 31974366.
2. Pons-Estel GJ, Alarcón GS, Scofield L, Reinlib L, Cooper GS. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum. 2010 Feb;39(4):257-68. doi: 10.1016/j.semarthrit.2008.10.007. Epub 2009 Jan 10. Review.
3. GfK Roper. (2012). Lupus Awareness Survey for the Lupus Foundation of America [Executive Summary Report]. Washington, DC.
4. Hong WANG, Yi-le REN, Jun CHANG, Luo GU, Ling-Yun SUN. A Systematic Review and Meta-analysis of Prevalence of Biopsy-Proven Lupus Nephritis
Arch Rheumatol. 2018 Mar; 33(1): 17–25. Published online 2017 Jul 25. doi: 10.5606/ArchRheumatol.2017.6127
5. Liu CC, Kao AH, Manzi S, Ahearn JM. Biomarkers in systemic lupus erythematosus: challenges and prospects for the future. Therapeutic Advances in Musculoskeletal Disease. 2013;5(4):210–233
6. Madhok R. Systemic lupus erythematosus: lupus nephritis. BMJ Clin Evid. 2015;2015:1123. Published 2015 Dec 18.
7. Hahn BH, McMahon MA, Wilkinson A, et al. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res. 2012;64(6):797-808.
8. Emily J. Sutton, Julie E. Davidson, Ian N. Bruce. The Systemic Lupus International Collaborating Clinics (SLICC) damage index: A systematic literature review. Seminars in Arthritis and Rheumatism, Volume 43, Issue 3, 2013, Pages 352-361. ISSN 0049-0172. 

You might also like

Fitness and Kidneys

A Kitchen for my Kidneys

People like me